Press release
Global Atropine Market Size, Share, Forecasts 2023 - 2033 | Top key players: Syndnexis, Amegen Inc., Bayer AG, Zoetis Inc., Bristol Myers Squibb Company, Eli Lilly and Company, AdvaCare Pharma, and others.
Global Atropine Market Size
Request To Download Free Sample copy of the report: https://www.sphericalinsights.com/request-sample/8197
The atropine market involves the development, production, and sale of atropine, a pharmaceutical compound used in various therapeutic applications. The increasing incidence of myopia and bradycardia is driving demand for atropine, with myopine being the most commonly marketed product. The FDA and DOD have collaborated on safety and efficacy requirements, leading to increased demand for atropine. The market is projected to exceed USD 279.99 million by 2033 due to these factors. the atropine market is expanding owing to its role in cardiac procedures and ophthalmology, particularly in treating eye disorders, particularly among the aging population, and its application in cardiac stress tests and surgeries. The growing need for surgical procedures and medical emergencies supports atropine's consistent market demand, which is further enhanced by its ability to effectively manage patients. However, adverse effects and contraindications derived from atropine usage may restrict the market growth.
The injectable segment held the greatest share in 2023 and is predicted to grow at a significant CAGR during the predicted period.
Based on the formulations, the global atropine market is categorized as injectables, oral, and ophthalmic. Among these, the injectable segment held the greatest share in 2023 and is predicted to grow at a significant CAGR during the predicted period. This is attributed to its rapid therapeutic effect, 100% bioavailability, sustained delivery, uniform absorption, precise dosing, and effectiveness in emergencies.
The ophthalmology segment accounted to grow at the highest pace in 2023.
Based on the indications, the global atropine market is categorized as gastroenterology, poisoning treatment, respiratory medicine, ophthalmology, cardiology, anesthesia, and others. Among these, the ophthalmology segment accounted to grow at the highest pace in 2023. The ophthalmology segment dominates the market due to ongoing clinical trials, research, and the increasing prevalence of eye disorders like myopia and atropine in diagnostic procedures.
The hospitals segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period.
Based on the end-user, the global atropine market is categorized as clinics, hospitals, ambulatory surgical centers, and retail pharmacies. Among these, the hospitals segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period. The segment's expansion is attributed to the availability of advanced services, individualized care, regular doctor visits, and intensive care unit (ICU) facilities for patients requiring immediate attention.
Buy Now this report: https://www.sphericalinsights.com/checkout/8197
North America is expected to hold the greatest share of the global atropine market over the forecast period
North America is expected to hold the greatest share of the global atropine market over the forecast period. North America's atropine market is dominated by advanced healthcare infrastructure, research investment, robust regulatory framework, chronic diseases, aging populations, leading pharmaceutical companies, and public awareness.
Asia Pacific is predicted to hold the fastest-growing region of the global atropine market throughout the estimated period. This is ascribed to healthcare sector expansion, increased investments, and high demand for improved services, bolstered by technological advancements.
Major key players in the global atropine market are Abbott Laboratories, Syndnexis, Amegen Inc., Bayer AG, Zoetis Inc., Bristol Myers Squibb Company, Eli Lilly and Company, AdvaCare Pharma, and others.
Access Full Report: https://www.sphericalinsights.com/reports/atropine-market
Key Target Audience
Market Players
Investors
End-users
Government Authorities
Consulting and Research Firm
Venture capitalists
Value-Added Resellers (VARs)
Recent Development
In February 2024, Santen Pharmaceutical Co Ltd. announced that it had applied for manufacturing and marketing approval in Japan for the product STN1012700/DE-127 (generic name: atropine sulfate hydrate ophthalmic solution. DE-127 is an eyedrop treatment developed by Santen and the Singapore Eye Research Institute to slow myopia progression, containing 0.025% atropine sulfate hydrate.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global atropine market based on the below-mentioned segments:
Global Atropine Market, By Formulation
Injectables
Oral
Ophthalmic
Global Atropine Market, By Indication
Gastroenterology
Poisoning treatment
Respiratory Medicine
Ophthalmology
Cardiology
Anesthesia
Others
Global Atropine Market, By End-User
Clinics
Hospitals
Ambulatory Surgical Centers
Retail Pharmacies
Global Atropine Market, By Regional
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Australia
Rest of Asia Pacific
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
UAE
Saudi Arabia
Qatar
South Africa
Rest of the Middle East & Africa
Related URLS
https://www.sphericalinsights.com/reports/smart-therapeutic-devices-market
https://www.sphericalinsights.com/reports/honeycomb-core-materials-market
https://www.sphericalinsights.com/reports/automotive-powder-metallurgy-components-market
https://www.sphericalinsights.com/reports/augmented-reality-in-e-commerce-market
https://www.sphericalinsights.com/reports/clip-in-human-hair-extension-market
https://www.sphericalinsights.com/reports/friction-reducing-device-market
https://www.sphericalinsights.com/reports/bakery-goods-manufacturing-market
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Follow Us: LinkedIn | Facebook | Twitter
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Atropine Market Size, Share, Forecasts 2023 - 2033 | Top key players: Syndnexis, Amegen Inc., Bayer AG, Zoetis Inc., Bristol Myers Squibb Company, Eli Lilly and Company, AdvaCare Pharma, and others. here
News-ID: 4179118 • Views: …
More Releases from Spherical Insights LLP
Digital Camcorders Market Poised for Remarkable Growth, set to Reach USD 4.07 Bi …
According to a research report published by Spherical Insights & Consulting, the Global Digital Camcorders Market Size is to Grow from USD 2.02 Billion in 2023 to USD 4.07 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 7.26% during the projected period.
A digital camcorder is a device that can record video to solid-state non-volatile storage, a hard drive, DVD, Digital8, MiniDV, and others. Certain digital camcorders may…
Know Worldwide specifications of the Global Butyl Rubber Market Size 2023-2033 | …
According to a research report published by Spherical Insights & Consulting, the Global Butyl Rubber Market Size is Expected to Grow from USD 3.65 Billion in 2023 to USD 5.42 Billion by 2033, at a CAGR of 4.03% during the forecast period 2023-2033.
Request To Download Free Sample copy of the report: https://www.sphericalinsights.com/request-sample/8202
The butyl rubber market is the market of synthetic rubber which is used in various applications…
Imitation Jewellery Market Size, Share, Analysis, Trends and Strategies 2023-203 …
According to a research report published by Spherical Insights & Consulting, the Global Imitation Jewellery Market Size Expected to Grow from USD 16.95 Billion in 2023 to USD 33.70 Billion by 2033, at a CAGR of 7.11% during the forecast period 2023-2033.
The goal is to offer the beauty and sophistication of fine jewellery without a hefty price tag. These objects are expertly made from a variety of materials, including…
Global Vodka Market Size, Share, And Industry Outlook Report, 2033
According to a research report published by Spherical Insights & Consulting, the Global Vodka Market Size Expected to Grow from USD 47.7 Billion in 2023 to USD 78.8 Billion by 2033, at a CAGR of 5.15% during the forecast period 2023-2033.
Vodka is a high-end distilled alcohol that is praised for its adaptability and neutral, crisp flavour. Made from fermented potatoes or grains, it goes through several distillations to attain a…
More Releases for Atropine
Global Atropine Sulfate Injection Market Research Report 2023
The global Atropine Sulfate Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Atropine Sulfate Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR…
Atropine Sulfate Market Trends, Business Overview, Industry Growth and Forecast …
The global atropine sulfate market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Atropine sulfate is used to treat a certain type of nerve agent and pesticide poisonings to reduce saliva, mucus, and other secretions during surgery. Therising market intervention by key market players is attracting the attention of investors across the globe. Atropine sulphate is used in the eye to increase the…
Atropine Market Analysis of Products, Type, Application and Forecast by 2026
Atropine Market Overview:
Atropine Market Report Represents various segments related to generally state-of-the-art business data and industry future examples with cautious assessment and examination. Atropine Market driving development of the existence sciences industry is altogether affecting business land in markets the nation over where this area has flourished. Clinical office, Lab and assembling space is rising quickly when different sorts of land, for example, office and retail are battling.
The Atropine Market…
Research report covers the Atropine Market share and Growth, 2017-2025
The most advanced study released by AMR on the Atropine market comprising key market segments such as Type, Application, Sales, Growth, Comprises details of companies manufacturing field, production volume, capacities, value chain, product specifications, raw material sourcing strategies, concentration rate, organizational structure, and distribution channel.
The research is a precise offset bridging both qualitative and quantitative data of Atropine market.
The study provides historical data to compare for evolving…
Global Atropine Sulfate Market Research Report
This report studies the global Atropine Sulfate market status and forecast, categorizes the global Atropine Sulfate market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Centroflora RESONANCE LABORATORIES ROLABO OUTSOURCING Minsheng Group Shaoxing Pharmaceutical China Resources Double-crane Pharmaceutical HENAN PURUI PHARMACEUTICAL Albany…
Global Atropine Sulfate Market Shows Impending Growth by 2022 with Positive CAGR
In the recent time, the atropine sulfate market shows progressive growth due to its use in the injection for treatment of bradycardia (low heart rate), reduce salivation and bronchial secretions before surgery. Further to elaborate the same, the Market Research Hub (MRH) has recently added an analyzed report titled as “Global Atropine Sulfate Market Research Report 2017” to its vast report repository. This study provides a detailed overview of the…
